SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 7.040+2.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FiloF who wrote (2177)3/10/2009 10:28:02 AM
From: richardred  Read Replies (1) of 7242
 
I agree. It's been mentioned by me and others. I expect some small biotechnology companies that have some good pipelines. They can be bought on the cheap as new funding is a lot harder these days. Also, IMO shareholder resistance from a quick premium would be a lot less.



A recent Forbes Pharma merger article.
forbes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext